164 related articles for article (PubMed ID: 1384792)
1. t(9;14)(p13;q32) denotes a subset of low-grade non-Hodgkin's lymphoma with plasmacytoid differentiation.
Offit K; Parsa NZ; Filippa D; Jhanwar SC; Chaganti RS
Blood; 1992 Nov; 80(10):2594-9. PubMed ID: 1384792
[TBL] [Abstract][Full Text] [Related]
2. Clusters of chromosome 9 aberrations are associated with clinico-pathologic subsets of non-Hodgkin's lymphoma.
Offit K; Parsa NZ; Jhanwar SC; Filippa D; Wachtel M; Chaganti RS
Genes Chromosomes Cancer; 1993 May; 7(1):1-7. PubMed ID: 7688550
[TBL] [Abstract][Full Text] [Related]
3. Non-Hodgkin's lymphomas with t(11;14)(q13;q32): a subset of mantle zone/intermediate lymphocytic lymphoma?
Leroux D; Le Marc'Hadour F; Gressin R; Jacob MC; Keddari E; Monteil M; Caillot P; Jalbert P; Sotto JJ
Br J Haematol; 1991 Mar; 77(3):346-53. PubMed ID: 2012759
[TBL] [Abstract][Full Text] [Related]
4. Translocations involving band 3q27 and Ig gene regions in non-Hodgkin's lymphoma.
Bastard C; Tilly H; Lenormand B; Bigorgne C; Boulet D; Kunlin A; Monconduit M; Piguet H
Blood; 1992 May; 79(10):2527-31. PubMed ID: 1586704
[TBL] [Abstract][Full Text] [Related]
5. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
6. Low-grade non-Hodgkin's lymphoma in a patient with systemic lupus erythematosus.
Robak T; Robak E; Bartkowiak J; Błoński JZ; Niewiadomska H; Wawrzyniak E
Leuk Lymphoma; 2001 May; 41(5-6):659-67. PubMed ID: 11378584
[TBL] [Abstract][Full Text] [Related]
7. Correlation between histology and immunophenotype in a series of 322 cases of non-Hodgkin's lymphoma.
Smith JL; Jones DB; Bell AJ; Wright DH
Hematol Oncol; 1989; 7(1):37-48. PubMed ID: 2642457
[TBL] [Abstract][Full Text] [Related]
8. The t(9;14)(p13;q32) translocation in B-cell non-Hodgkin's lymphoma.
Ohno H; Ueda C; Akasaka T
Leuk Lymphoma; 2000 Feb; 36(5-6):435-45. PubMed ID: 10784387
[TBL] [Abstract][Full Text] [Related]
9. Immunologic markers in non-Hodgkin's lymphoma.
Freedman AS; Nadler LM
Hematol Oncol Clin North Am; 1991 Oct; 5(5):871-89. PubMed ID: 1938759
[TBL] [Abstract][Full Text] [Related]
10. Follicular lymphoma with t(8;14)(q24;q32): a distinct clinical and molecular subset of t(8;14)-bearing lymphomas.
Ladanyi M; Offit K; Parsa NZ; Condon MR; Chekka N; Murphy JP; Filippa DA; Jhanwar SC; Dalla-Favera R; Chaganti RS
Blood; 1992 Apr; 79(8):2124-30. PubMed ID: 1562738
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric immunophenotyping including Bcl-2 detection on fine needle aspirates in the diagnosis of reactive lymphadenopathy and non-Hodgkin's lymphoma.
Laane E; Tani E; Björklund E; Elmberger G; Everaus H; Skoog L; Porwit-MacDonald A
Cytometry B Clin Cytom; 2005 Mar; 64(1):34-42. PubMed ID: 15669024
[TBL] [Abstract][Full Text] [Related]
12. Ki-1 antigen expression defines a favorable clinical subset of non-B cell non-Hodgkin's lymphoma.
Offit K; Ladanyi M; Gangi MD; Ebrahim SA; Filippa D; Chaganti RS
Leukemia; 1990 Sep; 4(9):625-30. PubMed ID: 2168505
[TBL] [Abstract][Full Text] [Related]
13. Leukaemic non-Hodgkin's lymphomas with hyperdiploid cells and t(11;14)(q13;q32): a subtype of mantle cell lymphoma?
Daniel MT; Tigaud I; Flexor MA; Nogueira ME; Berger R; Jonveaux P
Br J Haematol; 1995 May; 90(1):77-84. PubMed ID: 7786799
[TBL] [Abstract][Full Text] [Related]
14. Nonrandom rearrangement of chromosome 14 at band q32.33 in human lymphoid malignancies with mature B-cell phenotype.
Nishida K; Taniwaki M; Misawa S; Abe T
Cancer Res; 1989 Mar; 49(5):1275-81. PubMed ID: 2492904
[TBL] [Abstract][Full Text] [Related]
15. Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: correlations between recurrent aberrations, histology, and exposure to cytotoxic treatment.
Offit K; Jhanwar SC; Ladanyi M; Filippa DA; Chaganti RS
Genes Chromosomes Cancer; 1991 May; 3(3):189-201. PubMed ID: 1868033
[TBL] [Abstract][Full Text] [Related]
16. CD45RA expression by CD4 T lymphocytes in tumors invaded by B-cell non-Hodgkin's lymphoma (NHL) or Hodgkin's disease (HD).
Jacob MC; Favre M; Lemarc'Hadour F; Sotto MF; Bonnefoix T; Sotto JJ; Bensa JC
Am J Hematol; 1992 Jan; 39(1):45-51. PubMed ID: 1531569
[TBL] [Abstract][Full Text] [Related]
17. Concomitant delineation of surface Ig, B-cell differentiation antigens, and HLADR on lymphoid proliferations using three-color immunocytometry.
Segal GH; Edinger MG; Owen M; McNealis M; Lopez P; Perkins A; Linden MD; Fishleder AJ; Stoler MH; Tubbs RR
Cytometry; 1991; 12(4):350-9. PubMed ID: 1712263
[TBL] [Abstract][Full Text] [Related]
18. Ph-negative non-Hodgkin's lymphoma occurring in chronic phase of Ph-positive chronic myelogenous leukemia is defined as a genetically different neoplasm from extramedullary localized blast crisis: report of two cases and review of the literature.
Ichinohasama R; Miura I; Takahashi N; Sugawara T; Tamate E; Endoh K; Endoh F; Naganuma H; DeCoteau JF; Griffin JD; Kadin ME; Ooya K
Leukemia; 2000 Jan; 14(1):169-82. PubMed ID: 10637493
[TBL] [Abstract][Full Text] [Related]
19. Immunophenotyping of non-Hodgkin's lymphoma. Lack of correlation between immunophenotype and cell morphology.
Schuurman HJ; van Baarlen J; Huppes W; Lam BW; Verdonck LF; van Unnik JA
Am J Pathol; 1987 Oct; 129(1):140-51. PubMed ID: 3310650
[TBL] [Abstract][Full Text] [Related]
20. The malignant lymphomas of Kenya: morphology, immunophenotype, and frequency of Epstein-Barr virus in 73 cases.
Cool CD; Bitter MA
Hum Pathol; 1997 Sep; 28(9):1026-33. PubMed ID: 9308726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
